Wordt geladen...

Latest progress in tyrosine kinase inhibitors

Here we discuss the latest progress in development of some kinase inhibitors such as inhibitors of c-MET, LIM and Bcr-Abl kinases. Importantly, many oncogenic kinases signal via the mTOR pathway, suggesting a common target for drug combinations.

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Pospelova, Tatiana V., Pospelov, Valery A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012733/
https://ncbi.nlm.nih.gov/pubmed/24727648
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!